Madame Bioscience Public Company (MADAME) Fair Value & Analysis
Consumer Defensive · TH · Market cap 380M THB
Fair value as of: Jun 25, 2026
Analysis
Madame Bioscience Public Company (MADAME) currently trades at 0.4900 THB, while our model-based Fair Value estimate is 0.9600 THB — implying the stock looks roughly 95.9% undervalued today. We read business quality at 90/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Madame Bioscience Public Company Limited, together with its subsidiaries, engages in the food business in Thailand. It operates through Packaging Business, Retail Sales of Cosmetics, Food Business, and Other Business segments. The company offers various food products, including frozen processed and ready-to-eat food, chilled food, plant-based food, hemp food, processed food, and sauces under the Kitchen Plus and Look Chin Tip brands. It also provides flexible packaging, polyethylene terephthalate bottles, and food packaging trays for packaged food and beverages. In addition, the company engages in the manufacture and sale of plastic packaging, seafood, and processed meat; retail sale of cosmetics; advertising rental services in gas stations; restaurant business; network marketing; and trading activities. The company was formerly known as Global Consumer Public Company Limited and changed its name to Madame Bioscience Public Company Limited in July 2025. Madame Bioscience Public Comp…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Madame Bioscience Public Company (MADAME) undervalued?
What is the fair value of MADAME?
What is the quality score of MADAME?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.